Stattic 19983-44-9
Product Description
.cp_wz table {border-top: 1px solid #ccc;border-left:1px solid #ccc; } .cp_wz table td{border-right: 1px solid #ccc; border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;} .cp_wz table th {border-right: 1px solid #ccc;border-bottom: 1px solid #ccc; padding: 5px 0px 0px 5px;}
Molecular Weight:
211.19 Stattic, the first nonpeptidic small molecule, potently inhibits STAT3 activation and nuclear translocation with IC50 of 5.1 μM, highly selectivity over STAT1.
Biological Activity
Stattic inhibits binding of a phosphotyrosine-containing peptide derived
from the gp130 receptor to the STAT3 SH2 domain in a strongly
temperature-dependent manner. Stattic only has a very weak effect on
binding of a tyrosinephosphorylated peptide to the SH2-domain of the
tyrosine kinase Lck. And it doesn`t inhibit dimerization of two other
dimeric transcription factors (c-Myc/Max and Jun/Jun). It also inhibits
fluorescein-labeled phosphopeptides to the SH2 domains of STAT1 and
STAT5b.
Stattic selectively inhibits DNA binding of STAT3 homodimers at a
concentration of 10 μM. Shown to inhibit cellular phosphorylation of
STAT3 at Tyr705 with little effect towards STAT1 phosphorylation at
Tyr701 (in HepG2 cells) or the phosphorylation of JAK1, JAK2, and c-Src
(in MDA-MB-231 and MDA-MB-235S cells). Stattic increases the apoptotic
rate of STAT3-dependent breast cancer cell lines.
Protocol(Only for Reference)
Kinase Assay: [1]
Cell Assay: [2]
Animal Study: [2]
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.
Chemical Information
Molarity Calculator
Dilution Calculator
Molecular Weight Calculator
Contact us if you need more details on 19983-44-9. We are ready to answer your questions on packaging, logistics, certification or any Other aspects about Stattic 19983-44-9、19983-44-9 Stattic. If these products fail to match your need, please contact us and we would like to provide relevant information.
Molecular Weight:
211.19 Stattic, the first nonpeptidic small molecule, potently inhibits STAT3 activation and nuclear translocation with IC50 of 5.1 μM, highly selectivity over STAT1.
Biological Activity
Stattic inhibits binding of a phosphotyrosine-containing peptide derived
from the gp130 receptor to the STAT3 SH2 domain in a strongly
temperature-dependent manner. Stattic only has a very weak effect on
binding of a tyrosinephosphorylated peptide to the SH2-domain of the
tyrosine kinase Lck. And it doesn`t inhibit dimerization of two other
dimeric transcription factors (c-Myc/Max and Jun/Jun). It also inhibits
fluorescein-labeled phosphopeptides to the SH2 domains of STAT1 and
STAT5b.
Stattic selectively inhibits DNA binding of STAT3 homodimers at a
concentration of 10 μM. Shown to inhibit cellular phosphorylation of
STAT3 at Tyr705 with little effect towards STAT1 phosphorylation at
Tyr701 (in HepG2 cells) or the phosphorylation of JAK1, JAK2, and c-Src
(in MDA-MB-231 and MDA-MB-235S cells). Stattic increases the apoptotic
rate of STAT3-dependent breast cancer cell lines.
Protocol(Only for Reference)
Kinase Assay: [1]
High-Throughput Screening and Fluorescence Polarization Assays | Screening is performed at approximately 30 °C. The specificity of screening hits is validated in analogous assays for binding of the test compounds to the SH2 domains of STAT1, STAT5, and Lck. The final concentration of buffer components used for all FP assays is 10 mM HEPES (pH 7.5), 1 mM EDTA, 0.1% Nonidet P-40, 50 mM NaCl, and 10% DMSO. The absence of dithiothreitol is essential for inhibitory activity. The sequences of the peptides are: STAT3, 5-carboxyfluorescein-GY(PO3H2)LPQTV-NH2; STAT1, 5-carboxyfluorescein-GY(PO3H2)DKPHVL; STAT5, 5-carboxyfluorescein-GY(PO3H2)LVLDKW; and Lck, 5-carboxyfluorescein-GY(PO3H2)EEIP. For specificity analysis at 30 °C, Proteins are used at 150 nM (STAT1, STAT3, and STAT5). For specificity analysis at 37 °C, proteins are used at 370 nM (STAT3) or 100 nM (Lck). Proteins are incubated with test compounds in Eppendorf tubes at the indicated temperatures for 60 min prior addition of the respective 5-carboxyfluorescein labeled peptides (final concentration: 10 nM). Before measurement at room temperature, the mixtures are allowed to equilibrate for at least 30 min. Test compounds are used at the indicated concentrations diluted from a 20× stock in DMSO. Binding curves and inhibition curves are fitted with SigmaPlot. All competition curves are repeated three times in independent experiment |
---|
Cell Assay: [2]
Cell lines | Ly3 cells |
---|---|
Concentrations | ~2.5 μM |
Incubation Time | 48 h |
Method | MTS |
Animal Study: [2]
Animal Models | Ly3 parental NOD/SCID IL2R null xenograft |
---|---|
Formulation | |
Dosages | 3.75 mg/kg every day |
Administration | i.p. |
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species | Baboon | Dog | Monkey | Rabbit | Guinea pig | Rat | Hamster | Mouse |
Weight (kg) | 12 | 10 | 3 | 1.8 | 0.4 | 0.15 | 0.08 | 0.02 |
Body Surface Area (m2) | 0.6 | 0.5 | 0.24 | 0.15 | 0.05 | 0.025 | 0.02 | 0.007 |
Km factor | 20 | 20 | 12 | 12 | 8 | 6 | 5 | 3 |
Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
Animal A Km |
For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.
Rat dose (mg/kg) = mouse dose (22.4 mg/kg) × | mouse Km(3) | = 11.2 mg/kg |
rat Km(6) |
Chemical Information
Molecular Weight (MW) | 211.19 |
---|---|
Formula | C8H5NO4S |
CAS No. | 19983-44-9 |
Storage | 3 years -20℃Powder |
---|---|
6 months-80℃in solvent (DMSO, water, etc.) | |
Synonyms | |
Solubility (25°C) * | In vitro | DMSO | 42 mg/mL (198.87 mM) |
---|---|---|---|
Water | <1 mg/mL ( | ||
Ethanol | <1 mg/mL ( | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Chemical Name | Benzo[b]thiophene, 6-nitro-, 1,1-dioxide |
---|
Molarity Calculator
Dilution Calculator
Molecular Weight Calculator
Contact us if you need more details on 19983-44-9. We are ready to answer your questions on packaging, logistics, certification or any Other aspects about Stattic 19983-44-9、19983-44-9 Stattic. If these products fail to match your need, please contact us and we would like to provide relevant information.
Product Categories : JAK/STAT > STAT inhibitor
Other Products
Hot Products
Astragaloside AChlortetracycline HCl 64-72-2Paclitaxel 33069-62-4Dexamethasone Acetate 1177-87-3Dinaciclib (SCH727965) 779353-01-4CHIR-124 405168-58-3Ro3280 1062243-51-9TAME 901-47-3CCG-1423 285986-88-110058-F4 403811-55-2Dabigatran (BIBR 953) 211914-51-1H 89 2HCl 130964-39-5T0901317 293754-55-9Aprepitant 170729-80-3Turofexorate Isopropyl (XL335) 629664-81-9BMS-378806 357263-13-9